“Wang and colleagues present a systematic review of the research on adverse effects of medical cannabis use.
The authors found that most of the adverse events reported in the randomized clinical trials were not serious; dizziness was the most common.
These findings support the conclusions of the Institute of Medicine, that short-term use of cannabinoids for medical purposes has an acceptable safety profile.
This provides reassurance on the safety of prescribing cannabinoids and the newer cannabis extract for the short-term symptomatic relief…”
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413322/
